pediatric dermatology

Friday Pop Quiz 6/21/2024
Which of the following medications would be used to treat the following condition? A. MEK inhibitor B. mTOR inhibitor C. BRAF inhibitor D. VEGF inhibitor E. PD-1 inhibitor To find out the correct answer and read the explanation, click here. …
Ruxolitinib 1.5% Topical Cream for the Treatment of Pediatric Alopecia Areata | Case Report
pediatric alopeciaAlopecia areata (AA) is a common autoimmune disorder. Although its pathogenesis is not fully understood, AA involves CD8 T cell-mediated destruction of the hair follicle. Several treatment options exist; however, there is minimal evidence in the pediatric population. Currently, there are no curative treatments for AA. The literature suggests that Janus kinase (JAK) inhibitors may be an effective t …
pediatric alopecia
JAK Inhibitors in Pediatric Patients | Practical Pearls from the Expert
JAK InhibitorsBe excited about the new medications approved for use in pediatric patients, says Dr. A. Yasmine Kirkorian, chief of dermatology at Children’s National Hospital. Next Steps in Derm, in partnership with ODAC Dermatology, Aesthetic & Surgical Conference, interviewed Dr. Kirkorian about the use of JAK inhibitors in children. Should dermatology clinicians prescribe JAK inhibitors in this patient …
JAK Inhibitors
Patient Buzz: Rare Pediatric Skin Conditions | The Expert Weighs In
pediatric skin conditionsParade and other media outlets recently covered the story of actress Mandy Moore's son, who was diagnosed with Gianotti-Crosti syndrome. What should dermatology clinicians know about Gianotti-Crosti syndrome and other rare pediatric skin conditions? What should dermatology clinicians do when they are unsure of how to diagnose a pediatric skin condition?  For expert advice, I reached out to …
pediatric skin conditions
Rituximab Therapeutic Cheat Sheet
RituximabRituximab was the first monoclonal antibody approved for cancer treatment and now in dermatology, this medication has been life-altering for patients with the severe, autoimmune blistering disease, pemphigus vulgaris. We continue our series, Therapeutic Cheat Sheet, with a closer look at rituximab, which is FDA-approved for the treatment of pemphigus vulgaris, and is also used off label for other …
Rituximab